| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 75.2× | 23.7× | |
| Price / Book | 5.9× | 3.7× | |
| Price / Sales | 2.3× | 2.6× | |
| Price / Free cash flow | −20.6× | −8.7× | |
| EV / EBITDA | 28.4× | 16.1× | |
| Earnings yield | 1.3% | 2.2% | |
| Free cash flow yield | −4.9% | −3.4% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LENSE:LENSKARTLenskart Solutions Ltd · 🇮🇳 NSE | ₹630.95 | −1.41% | $11.53B | 225.2× | 5.6% | — |
RUNSE:RUBICONRubicon Research Ltd · 🇮🇳 NSE | ₹1,428.80 | −3.89% | $2.49B | 99.9× | 19.1% | — |
MONSE:MOLBIOMolbio Diagnostics Limited · 🇮🇳 NSE | ₹1,372.50 | −4.34% | $1.67B | 114.4× | 15.0% | — |
CONSE:CORONACorona Remedies Ltd · 🇮🇳 NSE | ₹2,023.60 | +0.68% | $1.3B | 66.5× | 24.8% | — |
SYNSE:SYMBIOTECSymbiotec Pharmalab Limited · 🇮🇳 NSE | ₹1,226.10 | −1.01% | $827.18M | 82.1× | 11.9% | — |
KPNSE:KPLKwality Pharmaceuticals Ltd · 🇮🇳 NSE | ₹3,470.00 | +3.09% | $377.74M | 51.7× | 20.3% | — |
SHNSE:SHUKRAPHARShukra Pharmaceuticals Ltd. · 🇮🇳 NSE | ₹68.36 | −0.38% | $316.39M | 136.9× | 24.5% | — |
FRNSE:FREDUNFredun Pharmaceuticals Ltd. · 🇮🇳 NSE | ₹1,389.90 | −3.37% | $240.42M | 72.5× | 11.7% | — |
SANSE:SAIPARENTSai Parenteral's Ltd · 🇮🇳 NSE | ₹482.75 | −0.05% | $224.38M | 149.6× | 2.9% | — |
BENSE:BETABeta Drugs Ltd · 🇮🇳 NSE | ₹1,666.60 | −3.08% | $194.37M | 46.0× | 16.9% | −5.3% |
